| Literature DB >> 16650175 |
F H Sakamoto1, G W B Colleoni, S P Teixeira, M Yamamoto, N S Michalany, F A Almeida, A K Chiba, V Petri, M A Fernandes, M S Pombo-de-Oliveira.
Abstract
Adult T-cell leukemia/lymphoma (ATLL) is a malignant proliferation of mature helper T lymphocytes,(1) and is caused by human T-lymphotropic virus type I (HTLV-I);(2) an HTLV-I infection endemic in the Caribbean, south-western Japan, South America and Africa.(3,4) Seroepidemiological studies suggest that it is also endemic in Brazil.(5) Although carriers of HTLV-I show polyclonal integration of virus in T lymphocytes, only patients with ATLL of various subtypes show monoclonal integration of HTLV-I in tumor cells.(6,7) Cutaneous T-cell lymphomas (CTCL) are a group of primary cutaneous lymphoproliferative diseases(8) with unknown etiology.(9) The two most common presentations of CTCL are mycosis fungoides (MF) and Sézary syndrome (SS).(10-13) However, both CTCL categories can easily resemble ATLL. Therefore, in HTLV-I endemic areas, differentiation between ATLL and CTCL must be performed, as they have different prognoses and treatment approaches.(14).Entities:
Mesh:
Substances:
Year: 2006 PMID: 16650175 DOI: 10.1111/j.1365-4632.2006.02687.x
Source DB: PubMed Journal: Int J Dermatol ISSN: 0011-9059 Impact factor: 2.736